Procore chair plans stock sale after option exercise
PROCORE TECHNOLOGIES, INC.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
PROCORE TECHNOLOGIES, INC. (PCOR) director and chairman of the board Craig F. Courtemanche filed a notice under Rule 144 indicating an intent to sell common stock through Morgan Stanley Smith Barney LLC after a planned stock option exercise on September 10, 2026.
The notice lists Procore common stock traded on the NYSE and reports that 151,955,338 shares of this class were outstanding as of September 10, 2026. It also discloses prior Rule 144 sales of Procore common stock by Courtemanche during July and August 2026.
Key Figures
Key Terms
Rule 144 regulatory
stock option exercise financial
aggregate market value financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What does the Form 144 filing mean for PROCORE TECHNOLOGIES, INC. (PCOR)?
What type of PCOR transaction is described in this Form 144?
Which broker is listed for the planned PCOR stock sale?
What prior PCOR sales by Craig F. Courtemanche are disclosed in this filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.